15 Worst Stock Picks of Cathie Wood
Cathie Wood, the chief ARK Investment Management, is often hailed as the champion of “disruptive innovation” at the stock market.
Invitae Corp (NVTA)
Get Email AlertsSector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 25,917,886 | $736,845 | +22% | 1.76% |
| 2. | Casdin Capital Eli Casdin | 12,203,669 | $346,950 | 8.63% | |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 9,873,488 | $280,703 | -4% | 1.23% |
| 4. | 163,385,000 | $199,645 | 3.89% | ||
| 5. | Redmile Group Jeremy Green | 5,317,477 | $151,176 | +15% | 2.63% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.50 | 44,444 | Officer, Director | 3,550,669 | 2018-04-02 | Filing | |
| $4.50 | 999,514 | Large Shareholder | 7,480,182 | 2018-03-28 | Filing | |
| $4.50 | 111,597 | Large Shareholder | 845,858 | 2018-03-28 | Filing | |
| $6.00 | 66,666 | Large Shareholder, Officer, Director | 3,506,225 | 2016-11-22 | Filing | |
| $6.25 | 15,000 | Director | 34,259 | 2016-11-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.89 | 29,675 | Officer | 246,050 | 2021-11-11 | Filing | |
| $28.06 | 3,675 | Officer, Director | 800,259 | 2021-10-22 | Filing | |
| $31.88 | 7,350 | Officer, Director | 748,934 | 2021-09-22 | Filing | |
| $24.86 | 15,337 | Officer | 73,980 | 2021-08-19 | Filing | |
| $25.42 | 21,231 | Officer | 246,050 | 2021-08-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 230 | $3,512 | 0% | |
| 2. | 202,641 | $3,095 | 1.94% | |
| 3. | 144,000 | $2,199 | 0.08% | |
| 4. | 115,800 | $1,768 | 0.47% | |
| 5. | 53,202 | $812 | 0.03% |
News See All
9 Latest Stock Picks of Chinese Billionaire Chen Tianqiao’s Shanda Asset Management
In this piece, we will take a look at the 9 latest stock picks of Chinese billionaire Chen Tianqiao's Shanda Asset Management.
Hedge Funds Are Selling InVitae Corporation (NVTA)
We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.
Cathie Wood’s ARK Portfolio: Top 5 Losers
In this article, we discuss the 5 biggest losers in the portfolio of Cathie Wood's ARK.
5 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio
In this article, we discuss the 5 growth stocks under $20 in billionaire Ken Fisher's portfolio.
10 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this article, we discuss the 10 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Cathie Wood Portfolio: 10 Biggest Losers
In this article, we discuss the 10 biggest losers in the stock portfolio of Cathie Wood.
Cathie Wood is Buying These 5 Stocks
Pacific Biosciences of California, Inc. (NASDAQ:PACB) manufactures genomic sequencing systems.
10 New Stock Picks of Billionaire Ken Fisher
Ken Fisher oversees Fisher Asset Management, a hedge fund based in Washington that had a portfolio value of more than $160 billion at the end of the third quarter of 2021, according to the latest 13F ...
Hedge Funds Are Cashing Out Of InVitae Corporation (NVTA)
In this article we will take a look at whether hedge funds think InVitae Corporation (NYSE:NVTA) is a good investment right now.
Billionaire Hedge Funds
